London — Canopy Growth has joined forces with a UK researcher of cannabis-based therapies after the British government moved to liberalise the use of medical marijuana. The new company, formed with Beckley Canopy Therapeutics, aims to make products available in Britain from early 2019. The government made it legal last November for specialist doctors to prescribe medical marijuana for patients with severe clinical need. The decision came after studies showed that it could benefit children with conditions such as severe epilepsy, although the government said it was not a step toward legalising cannabis for recreational use. “We are witnessing the birth of the UK medical cannabis industry, an industry borne out of the unmet clinical needs of patients across the country,” said Marc Wayne, co-managing director of the venture, called Spectrum Biomedical UK. The partnership “is testament to the importance of the opportunity to help patients access the medicine here in the UK,” he said. Th...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.